Pacira | PCRX - EPS Earnings Per Share


Pacira reported $0.6 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.76 0.70 Oct/29
FY2026Q2 Jun/2026 0.65 0.74 Aug/04
FY2026Q1 Mar/2026 0.60 0.73 0.62 Apr/30
FY2025Q4 Dec/2025 0.91 0.91 Feb/26
FY2025Q3 Sep/2025 0.70 0.66 0.79 Nov/06




Eps Change Date
Astellas Pharma JPY 24.29 31.75 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cara Therapeutics USD -0.59 4.45 Sep/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novo Nordisk DKK 10.91 4.87 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026
Xoma USD -1.59 2.43 Sep/2024
Zoetis USD 1.53 0.05 Mar/2026